Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HKN1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 247 | 251 | PF00656 | 0.347 |
CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.526 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.438 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.530 |
DEG_SPOP_SBC_1 | 183 | 187 | PF00917 | 0.549 |
DEG_SPOP_SBC_1 | 199 | 203 | PF00917 | 0.381 |
DOC_CYCLIN_yCln2_LP_2 | 2 | 8 | PF00134 | 0.239 |
DOC_MAPK_gen_1 | 133 | 141 | PF00069 | 0.452 |
DOC_MAPK_MEF2A_6 | 220 | 228 | PF00069 | 0.291 |
DOC_MAPK_MEF2A_6 | 283 | 291 | PF00069 | 0.357 |
DOC_MAPK_MEF2A_6 | 3 | 10 | PF00069 | 0.347 |
DOC_PP2B_LxvP_1 | 2 | 5 | PF13499 | 0.259 |
DOC_PP2B_LxvP_1 | 207 | 210 | PF13499 | 0.451 |
DOC_USP7_MATH_1 | 188 | 192 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.474 |
DOC_USP7_MATH_1 | 277 | 281 | PF00917 | 0.611 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.374 |
LIG_14-3-3_CanoR_1 | 101 | 110 | PF00244 | 0.544 |
LIG_14-3-3_CanoR_1 | 244 | 253 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 28 | 32 | PF00244 | 0.474 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.445 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.482 |
LIG_FHA_1 | 316 | 322 | PF00498 | 0.501 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.301 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.291 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.532 |
LIG_LIR_Apic_2 | 250 | 256 | PF02991 | 0.586 |
LIG_LIR_Gen_1 | 136 | 144 | PF02991 | 0.432 |
LIG_LIR_Gen_1 | 271 | 277 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 29 | 35 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 7 | 17 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 136 | 141 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 29 | 34 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 7 | 13 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.370 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.434 |
LIG_SH2_NCK_1 | 104 | 108 | PF00017 | 0.373 |
LIG_SH2_NCK_1 | 253 | 257 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 104 | 108 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 31 | 35 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 312 | 315 | PF00017 | 0.388 |
LIG_SH3_3 | 190 | 196 | PF00018 | 0.584 |
LIG_SUMO_SIM_par_1 | 4 | 9 | PF11976 | 0.343 |
LIG_TRAF2_1 | 88 | 91 | PF00917 | 0.491 |
LIG_WRC_WIRS_1 | 92 | 97 | PF05994 | 0.486 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.475 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.369 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.498 |
MOD_CK2_1 | 169 | 175 | PF00069 | 0.561 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.497 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.554 |
MOD_GlcNHglycan | 174 | 178 | PF01048 | 0.674 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.751 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.493 |
MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.552 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.383 |
MOD_GlcNHglycan | 272 | 275 | PF01048 | 0.504 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.293 |
MOD_GlcNHglycan | 338 | 341 | PF01048 | 0.594 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.587 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.536 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.600 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.707 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.395 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.305 |
MOD_N-GLC_1 | 47 | 52 | PF02516 | 0.487 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.449 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.476 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.651 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.476 |
MOD_NEK2_1 | 336 | 341 | PF00069 | 0.532 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.476 |
MOD_OFUCOSY | 46 | 51 | PF10250 | 0.474 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.379 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.462 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.513 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.340 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.441 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.446 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.370 |
TRG_DiLeu_BaLyEn_6 | 237 | 242 | PF01217 | 0.436 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 272 | 275 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.375 |
TRG_ER_diArg_1 | 132 | 134 | PF00400 | 0.528 |
TRG_Pf-PMV_PEXEL_1 | 169 | 174 | PF00026 | 0.473 |
TRG_Pf-PMV_PEXEL_1 | 98 | 102 | PF00026 | 0.386 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5N9 | Leptomonas seymouri | 54% | 100% |
A0A1X0NS57 | Trypanosomatidae | 28% | 100% |
A0A3Q8IG17 | Leishmania donovani | 77% | 97% |
A0A422N888 | Trypanosoma rangeli | 30% | 100% |
D0AAC8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9B319 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q4Q535 | Leishmania major | 76% | 100% |
V5BCW8 | Trypanosoma cruzi | 32% | 100% |